WEIGAO GROUP (01066.HK): Exchange Approves H Share Full Circulation

On 20 November 2026, WEIGAO GROUP (01066.HK) said the Exchange approved listing of 48.3 million H Shares converted from unlisted shares held by nine shareholders.

NewTimeSpace News: On 20 November 2026, Shandong Weigao Group Medical Polymer Company Limited (stock code: 01066.HK) announced that on 18 November 2026 it received the approval granted by the Stock Exchange for the listing of and permission to deal in 48,300,000 H Shares, being the maximum number of unlisted shares to be converted under the conversion and listing. The Company had previously announced on 29 September 2025 and 1 April 2026 its application for H Share Full Circulation and the filing notice issued by the CSRC.

The conversion and listing involves nine participating shareholders in aggregate, all being Tianjin Yangfan No.1 to No.9 Enterprise Management Consulting Partnerships (Limited Partnership), which together hold 48,300,000 unlisted shares, representing about 1.06% of the total issued shares upon completion; each will convert between 4,750,000 and 7,450,000 shares, or about 0.10% to 0.16%.

On shareholding structure, as at the date of the announcement the Company had 48,300,000 unlisted shares, or 1.06% of the total issued shares, and 4,522,332,324 H Shares, or 98.94%, with a total of 4,570,632,324 shares. Upon completion, unlisted shares will fall to zero and H Shares will rise to 4,570,632,324, or 100.00%, with the total number of issued shares unchanged. The Company said it will complete the procedures relating to the H Share conversion and will make further announcements on the progress of the H Share Full Circulation and the conversion and listing under the Inside Information Provisions and/or the Listing Rules.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.